Last reviewed · How we verify

Locobase® REPAIR

Astellas Pharma Europe B.V. · FDA-approved active Small molecule

Locobase® REPAIR is an emollient and skin barrier repair product that restores skin hydration and protects damaged skin through occlusive and humectant ingredients.

Locobase® REPAIR is an emollient and skin barrier repair product that restores skin hydration and protects damaged skin through occlusive and humectant ingredients. Used for Dry skin and skin barrier dysfunction, Symptomatic relief of xerosis and atopic dermatitis-prone skin.

At a glance

Generic nameLocobase® REPAIR
SponsorAstellas Pharma Europe B.V.
Drug classEmollient/skin barrier repair product
ModalitySmall molecule
Therapeutic areaDermatology
PhaseFDA-approved

Mechanism of action

Locobase® REPAIR is a topical formulation designed to repair and maintain the skin barrier function in dry and damaged skin conditions. It combines emollients and occlusives to reduce transepidermal water loss and restore skin hydration. The product is intended for symptomatic relief of dry skin and support of skin barrier recovery.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: